Company Presentation • 05 Mar 2024 21:30
Company Presentation • 08 Feb 2024 05:30
Company Presentation • 17 Jan 2024 05:30
Company Presentation • 11 Jul 2023 20:30
No more presentations
ENTITY
REGENXBIO Inc (RGNX US)
REGENXBIO Inc (RGNX US)
27
Analysis
Health Care • United States
REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
x